TY - GEN
T1 - Heterogeneity in cancer dynamics
T2 - 2015 American Control Conference, ACC 2015
AU - Dobbe, Roel
AU - Chang, Young Hwan
AU - Korkola, James
AU - Gray, Joe
AU - Tomlin, Claire
N1 - Publisher Copyright:
© 2015 American Automatic Control Council.
PY - 2015/7/28
Y1 - 2015/7/28
N2 - Breast cancer tumors have inherently heterogeneous cell types that respond differently to treatments. Although there is a wealth of studies describing canonical cell signaling networks, little is known about how these networks operate in different cancer cells and treatments. This paper proposes a method to split a set of responses gathered from experiments on different cancer cells up into common and specific components. The key to this retrieval is the derivation of a linear timevarying model of the shared dynamics among the different cell lines. A convex optimization problem is derived that retrieves both the model and the common and specific responses without a priori information. The method is tested on synthetic data, and verifies known facts when tested on a biological data set with protein expression data from breast cancer experiments. The technique can be used to analyze specific responses to understand what treatments can be combined to persistently treat a heterogeneous cancer tumor. The linear time-varying model sheds light on how proteins interact over time.
AB - Breast cancer tumors have inherently heterogeneous cell types that respond differently to treatments. Although there is a wealth of studies describing canonical cell signaling networks, little is known about how these networks operate in different cancer cells and treatments. This paper proposes a method to split a set of responses gathered from experiments on different cancer cells up into common and specific components. The key to this retrieval is the derivation of a linear timevarying model of the shared dynamics among the different cell lines. A convex optimization problem is derived that retrieves both the model and the common and specific responses without a priori information. The method is tested on synthetic data, and verifies known facts when tested on a biological data set with protein expression data from breast cancer experiments. The technique can be used to analyze specific responses to understand what treatments can be combined to persistently treat a heterogeneous cancer tumor. The linear time-varying model sheds light on how proteins interact over time.
UR - http://www.scopus.com/inward/record.url?scp=84940920035&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84940920035&partnerID=8YFLogxK
U2 - 10.1109/ACC.2015.7172021
DO - 10.1109/ACC.2015.7172021
M3 - Conference contribution
AN - SCOPUS:84940920035
T3 - Proceedings of the American Control Conference
SP - 4398
EP - 4403
BT - ACC 2015 - 2015 American Control Conference
PB - Institute of Electrical and Electronics Engineers Inc.
Y2 - 1 July 2015 through 3 July 2015
ER -